NCT06457971 Anovo Surgical System in Ventral Hernia
| NCT ID | NCT06457971 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Momentis Surgical |
| Condition | Ventral Hernia |
| Study Type | INTERVENTIONAL |
| Enrollment | 50 participants |
| Start Date | 2024-01-14 |
| Primary Completion | 2025-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 50 participants in total. It began in 2024-01-14 with a primary completion date of 2025-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The study is aimed to clinically assess the AnovoTM Surgical System in ventral hernia procedures. Extensive preclinical testing of the system's integrity and safety has been performed to assure adequate safety for this trial.
Eligibility Criteria
Inclusion Criteria: * Subject is at least 18 years old. * Subjects able to provide written informed consent. * Subject deemed eligible candidate by surgeon and will comply with the study procedures. * Subjects with ventral hernia. * Subjects with ASA grade I to III. * Subject must sign and date informed consent prior to treatment. * Subject can undergo general anesthesia per anesthesiologist assessment. Exclusion Criteria: * Women who are pregnant or breast-feeding or who wish to become pregnant during the period of the clinical investigation. * Subject has medical condition, which in the judgement of the investigator makes the subject a poor candidate for the investigational procedure. * Participation in another clinical trial that is in the active phase. * Subject unwilling or inability to follow procedures outlined in the protocol. * Subjects who are not suitable for robotic surgery, the Subject will be excluded from the study and the will be considered a screen failure and the surgeon will proceed with a standard multiport laparoscopic Hernia repair. * Subjects who present any adverse event before use the Anovo Surgical System ("Anovo") that can affect evaluation of safety and performance of Investigational Device.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06457971 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Ventral Hernia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06457971 currently recruiting?
Yes, NCT06457971 is actively recruiting participants. Contact the research team at maya.lieb@momentissurgical.com for enrollment information.
Where is the NCT06457971 trial being conducted?
This trial is being conducted at Bonheiden, Belgium, Jerusalem, Israel.
Who is sponsoring the NCT06457971 clinical trial?
NCT06457971 is sponsored by Momentis Surgical. The trial plans to enroll 50 participants.